Yahoo HomeBlake Griffin with a 3-pointer vs the Houston Rockets
Blake Griffin (Detroit Pistons) with a 3-pointer vs the Houston Rockets, 01/22/2021
Make Yahoo Your Homepage
Discover something new every day from News, Sports, Finance, Entertainment and more!
Blake Griffin (Detroit Pistons) with a 3-pointer vs the Houston Rockets, 01/22/2021
New York, New York--(Newsfile Corp. - February 26, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of SolarWinds Corporation ("SolarWinds") (NYSE: SWI) between October 18, 2018 and December 17, 2020. You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Western District of Texas. To get more information ...
The TV star said it was time to say goodbye to the Channel 4 show.
The European Union's medicines regulator is expected to recommend drugmaker Johnson & Johnson's COVID-19 vaccine on March 11, Bloomberg News reported https://bloom.bg/3stLMZR on Friday, a move that could give the region its fourth coronavirus vaccine. The U.S. drugmaker said earlier this month it had submitted a conditional marketing application for its vaccine with the European Medicines Agency (EMA). Last week, the regulator said it could issue an opinion by mid-March on whether to approve J&J's vaccine under a speedy review.
After the November election, 36 U.S. states have now legalized medical marijuana and 15 allow recreational marijuana. Innovative Industrial owns 67 properties across 17 states, with 5.8 million square feet of rentable property.
). The ongoing COVID-19 pandemic has increased the awareness among the consumers for the usage of disposable hygiene products, including adult diapers as a precautionary measure, driven by COVID-19 fears and emergency mandates to reduce and stop the spread of communicable diseases as hospitals are inaccessible, coupled with the growing demand for health and wellness products worldwide; this is a key factor that is anticipated to drive the growth of the market studied.New York, Feb. 26, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Adult Diaper Market - Growth, Trends, Covid-19 Impact and Forecasts (2021 - 2026)" - https://www.reportlinker.com/p06028487/?utm_source=GNW Further, COVID-19 has also resulted in a generation of opportunities for many private players to emerge in the markets, to cater to the inflated demand. Moreover, COVID-19 has led to a major consumer shift, as customers are no more brand loyal in developing countries and are trying new brands in the low-stock environment.For instance, Nobel Hygiene, which manufactures the Friends brand of adult diapers, witnessed double-digit growth starting March 2020 and the company created volunteer groups to deliver diapers to the doorsteps of consumersThe growing geriatric population increased the affordability of diapers, rise in individuals suffering from severe incontinence, and increasing awareness towards improving hygiene conditions are among the primary growth factors for the market. Also, the increase of the adult diapers market size is also likely to be positively impacted by the growth in online retail for personal hygiene products. The success of online retailing can be attributed to increased customer outreach, inventory management cost-cutting, and improved product visibility.Key Market TrendsIncreasing Penetration of E-Commerce ChannelIn terms of distribution channel, E-commerce anticipated being the most significant contributor to the increasing consumption due to the increased probability of incontinence among them. In developing economies, key players are taking initiatives to spread awareness and dignify the market with the help of advertisements and promotion campaigns that are helping to increase the acceptance of the adult diaper among the aged population. For instance, in 2017, Friends Adult Diapers which is based in India launched its first ad campaign to spread awareness about adult diaper which can bring about a life-altering change in the lives.As per reports published by the US Census Bureau, in 2017, the value of e-commerce sales of pharmaceuticals and beauty aids was 35.7 billion U.S. dollars, up from 31.4 billion U.S. dollars in 2016. Therefore, this increase in the online platform is expected to contribute towards the increasing demand for adult diaper further during the forecast period.Asia-Pacific Remain the Fastest Growing MarketNorth America is likely to witness significant market share over the forecast period due to the growing acceptance of adult diaper use among the aged population in countries like the US and Canada. In developing economies, some consumers who are traveling prefer diapers over public toilets, owing to poor conditions of toilets in the countries. Europe region is witnessing the fastest regional markets growth and is expected to remain the same over the forecast period. In Europe, adult diapers are supposed to overtake the baby diapers market owing to the increasing aged population across the region especially in countries like Germany, Italy, Greece, France, etc. In the Asia-Pacific region, Japan is expected to witness significant demand for adult diapers as more than 26.3% of the population is over 65 years oil in the country. Majority of new entrants in the market are focusing to expand their business in emerging economies, especially in Asia-Pacific and South America region.Competitive LandscapeGlobal adult diaper market witnesses high competition, with a considerable number of regional and global players. An advanced distribution network gives an upper edge to the manufacturers to expand their range of products across the globe. Moreover, it is crucial for players to continuously innovate to operate and grow in the market due to the rapidly changing consumer demands and preferences. Unicharm Corporation, First Quality Enterprises, Inc., Kimberly-Clark Corporation, and Attends Healthcare Products, Inc.are some of the major players offering adult diapers across the globe.Reasons to Purchase this report:- The market estimate (ME) sheet in Excel format- 3 months of analyst supportRead the full report: https://www.reportlinker.com/p06028487/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001
The Indian rupee and bonds weakened on Friday as global markets were rocked overnight by a surge in U.S. treasury yields to their highest levels since the pandemic began. The Indian currency fell 1.1% on the week, having risen for the previous six weeks on the back of India's improved economic outlook and broad dollar weakness. Rahul Gupta, head of research-currency at Emkay Global Financial Services said the overall picture can be dire for the rupee while projecting the dollar/rupee pair to trade above 73.25 levels in the near-term, with the rupee likely to run into resistance if it strengthened to the 72.50 level.
The Kuala Lumpur-listed company floated the idea to seek a listing on the Hong Kong stock exchange in September, after its profit soared more than 17-times for the quarter ended August last year. Top Glove said in a statement on Friday it will issue up to 1.50 billion shares, but determine the issue price at a later date and maintain its existing primary listing on the main market of Bursa Securities Malaysia. "A dual primary listing in Hong Kong would create an expanded global platform that can enable the Group to raise capital for business growth, geographic expansion, and strategic investments and acquisitions," Executive Chairman Lim Wee Chai said.
The "Pharmacovigilance and Drug Safety Software Market Research and Outlook, 2020 - Trends, Growth Opportunities and Forecasts to 2028" report has been added to ResearchAndMarkets.com's offering.
Feb. 26—A Wayne County Jail inmate was ordered Thursday to stand trial in the strangulation slaying of Wayne County sheriff's Cpl. Bryant Searcy. Deandre Williams, 28, is charged with killing Searcy last September during a struggle inside the jail before Williams escaped. He was jail for an alleged carjacking. Williams will stand trial on charges of first-degree murder, murdering a police ...
Grealish remains injured for Aston Villa’s trip to Leeds.
Chicago lived up to its name as the Windy City on February 21 when powerful gusts moved ice that was resting on top of a frozen Lake Michigan.Footage by Chicago man Alex Perez shows strong waves moving large blocks of ice around the lake’s surface, making for a strangely mesmerizing sight.“The wind was not playing yesterday at the lakefront,” Perez said in a February 22 tweet. Credit: Alex Perez via Storyful
Dublin, Feb. 26, 2021 (GLOBE NEWSWIRE) -- The "Irritable Bowel Syndrome with Constipation Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2020 to 2028" report has been added to ResearchAndMarkets.com's offering. The global irritable bowel syndrome with constipation drugs market is rising at a significant pace, projected to rise at a CAGR of 6.1% during the estimated period from 2020 to 2028, starting from US$ 1,450.9 Mn in 2019.Irritable bowel syndrome (IBS) is defined as persistent abdominal discomfort and pain occurring with changed bowel habits. This condition is classified into three types centered upon the prevalent bowel habits; IBS with diarrhea (IBS-D), IBS with constipation (IBS-C), and IBS with mixed presentations (IBS-M). It is among the most common gastrointestinal disorders with a worldwide prevalence of approximately 11%. As of 2019, more than 30 million individuals older than age 19 suffered from IBS across key national markets namely the U.S., U.K. France, Italy, Germany, Japan, and Spain. The IBS market is observed to be underpenetrated and hence is deemed attractive for pharmaceutical manufacturers in the GI drugs market. The majority of IBS patients are women and one-third IBS patients experience constipation as a primary syndrome. Awareness about the attractiveness of the market potential and a growing understanding of disease pathophysiology render growth potential and further evolution of the IBS-C drugs market.This report on global irritable bowel syndrome with constipation (IBS-C) drugs evaluates the current market scenario and predicts future market trends for the commercialized and pipeline drugs for IBS-C treatment for the period from 2018 to 2028. IBS is among the most commonly prevalent gastrointestinal diseases for which the exact cause is not determined. However, the recent developments in research on this issue have led to the introduction of several novel disease treatment and management solutions.In addition, lockdown restrictions and the need to maintain social distancing due to the ongoing COVID-19 pandemic have resulted in more number of people staying at home. Hence, lack of exercise and consumption of spicy food has resulted in the development of irritable bowel syndrome across all age groups. In addition, irrational intake of medication has also been linked to causing a change in the gut microflora causing underlying factors for the occurrence of IBS, thereby the irritable bowel syndrome with constipation drugs market is expected to witness significant growth during the forecast period from 2020 to 2028.In 2019, North America dominated the regional irritable bowel syndrome with constipation drugs market, due to increased intake of irrational medications and lack of exercise, thereby causing irritable bowel syndrome associated with constipation. Existence of a well-developed healthcare infrastructure and the presence of major market players such as Abbott Laboratories, Inc., Ardelyx. Inc., Astellas Pharma Inc., AstraZeneca Plc., Bayer AG, Fresenius Kabi AG., and others further accentuate the market growth in the region.The Asia Pacific region is expected to be the fastest-growing region during the forecast period owing to the increasing consumption of spicy food, drastically altering the bowel peristaltic activity and increasing public health awareness regarding gastrointestinal disorders and its effective management will drive the market growth in Asia Pacific region.This report is a comprehensive research study of the global irritable bowel syndrome with constipation drugs market that elaborates the major trends in the market based on quantitative and qualitative research. This report provides a detailed description of global irritable bowel syndrome with constipation drugs market segmenting market by drug types, prescription type, and geography. This report aids the market stakeholders to make improved decisions and strategies in the irritable bowel syndrome with constipation drugs market.Historical & Forecast Period:This study report represents analysis for each segment from 2018 to 2028 considering 2019 to be the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period from 2020 to 2028.The current report also comprehends qualitative and qualitative market valuation factors such as key market drivers, market trends, restraints, and opportunities that give a better market understanding of the overall irritable bowel syndrome with constipation drugs market. Additionally, the global report also comprises a graphical representation of the competitive landscape based on their market initiatives and strategies, product portfolio, and business strengths.Key questions answered in this report: What are the current market trends and dynamics in the irritable bowel syndrome with constipation drugs market and valuable opportunities for emerging players?Which segment accounts for the fastest CAGR during the forecast period?What are the drivers of the irritable bowel syndrome with constipation drugs market?Notable developments going on in the irritable bowel syndrome with constipation drugs market.What is the market trend and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?A comparative scenario for all the segments for the years 2019 (actual) and 2028 (forecast) Key Topics Covered: Chapter 1. PrefaceChapter 2. Executive Summary2.1. Global Irritable Bowel Syndrome with Constipation Drugs Market Portraiture2.2. Global Irritable Bowel Syndrome with Constipation Drugs Market, by Drug Type, 2019 (US$ Mn)2.3. Global Irritable Bowel Syndrome with Constipation Drugs Market, by Geography, 2019 (US$ Mn)Chapter 3. Irritable Bowel Syndrome with Constipation Drugs Market Analysis3.1. Irritable Bowel Syndrome with Constipation Drugs Market Overview3.2. Market Dynamics3.2.1. Market Drivers3.2.2. Challenges3.2.3. Opportunities3.3. Attractive Investment Proposition, by Geography, 203.4. Competitive Landscape, by Key Players, 20Chapter 4. Global Irritable Bowel Syndrome with Constipation Drugs Market, by Drug Type, 2018-2028 (US$ Mn)4.1. Preface4.1.1. Attractive Investment Proposition, by Drug Type, 204.2. Lubiprostone4.3. Linaclotide4.4. Stimulant Irritable Bowel Syndrome with Constipation Drugs - Bisacodyl4.5. Osmotic Irritable Bowel Syndrome with Constipation Drugs4.5.1. Lactulose4.5.2 Polyethylene Glycol4.6. Pipeline Analysis (Market estimations by 2028)Chapter 5. Global Irritable Bowel Syndrome with Constipation Drugs Market, by Prescription Type, 2018-2028 (US$ Mn)5.1. Preface5.1.1. Attractive Investment Proposition, by Prescription Type, 205.2. Prescribed5.3. Over the Counter DrugsChapter 6. Global Irritable Bowel Syndrome with Constipation Drugs Market, by Geography, 2018 - 2028 (US$ Mn)6.1. Overview6.2. North America Irritable Bowel Syndrome with Constipation Drugs Market Analysis, 2018 - 2028 (US$ Mn)6.2.1. North America Irritable Bowel Syndrome with Constipation Drugs Market, by Drug Type, 2018 - 2028 US$ Mn)6.2.2. North America Irritable Bowel Syndrome with Constipation Drugs Market, by Country, 2018 - 2028 (US$ Mn)6.2.2.1. U.S.6.2.2.2. Canada6.3. Europe Irritable Bowel Syndrome with Constipation Drugs Market Analysis, 2018 - 2028 (US$ Mn)6.3.1. Europe Irritable Bowel Syndrome with Constipation Drugs Market, by Drug Type, 2018 - 2028 US$ Mn)6.3.2. Europe Irritable Bowel Syndrome with Constipation Drugs Market, by Country, 2018 - 2028 (US$ Mn)6.3.2.1. U.K.6.3.2.2. Germany6.3.2.3. Rest of Europe6.4. Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Market Analysis, 2018 - 2028 (US$ Mn)6.4.1. Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Market, by Drug Type, 2018 - 2028 US$ Mn)6.4.2. Asia Pacific Irritable Bowel Syndrome with Constipation Drugs Market, by Country, 2018 - 2028 (US$ Mn)6.4.2.1. China6.4.2.2. Japan6.4.2.3. Rest of APAC6.5. Latin America Irritable Bowel Syndrome with Constipation Drugs Market Analysis, 2018 - 2028 (US$ Mn)6.5.1. Latin America Irritable Bowel Syndrome with Constipation Drugs Market, by Drug Type, 2018 - 2028 US$ Mn)6.5.2. Latin America Irritable Bowel Syndrome with Constipation Drugs Market, by Country, 2018 - 2028 (US$ Mn)6.5.2.1. Brazil6.5.2.2. Mexico6.5.2.3. Rest of Latin America6.6. Middle East & Africa (MEA) Irritable Bowel Syndrome with Constipation Drugs Market Analysis, 2018 - 2028 (US$ Mn)6.6.1. MEA Irritable Bowel Syndrome with Constipation Drugs Market, by Drug Type, 2018 - 2028 (US$ Mn)6.6.2. MEA Irritable Bowel Syndrome with Constipation Drugs Market, by Country, 2018 - 2028 (US$ Mn)6.6.2.1. GCC6.6.2.2. Rest of MEAChapter 7. Company Profiles7.1. Abbott Laboratories, Inc.7.1.1. Business Description7.1.2. Financial Information (Subject to data availability)7.1.3. Product Portfolio7.1.4. Key Developments7.2. Ardelyx, Inc.7.3. Astellas Pharma Inc.7.4. AstraZeneca Plc.7.5. Bayer AG7.6. Fresenius Kabi AG7.7. Ironwood Pharmaceuticals, Inc.7.8. Sanofi S.A.7.9. SK Biopharmaceuticals Co., Ltd.7.10. Sucampo AG7.11. Synergy Pharmaceuticals, Inc.7.12. Synthetic Biologics, Inc.For more information about this report visit https://www.researchandmarkets.com/r/yxq6cx CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Feb. 26—DETROIT — Sam Gagner didn't score a goal in his first 13 games but made up for lost time Thursday — with a bit of help from Nashville goaltender Pekka Rinne. Gagner scored two seeing-eye goals, then ended things with an empty-net goal, lifting the Red Wings to a 5-2 victory over Nashville — the five goals, a season-high for the offensively starved Wings. Gagner scored the tiebreaker — ...
Central banks in Asia struggled to smother a selloff in global bonds on Friday, piling pressure on their bigger peers to do more, as spooked investors sold assets to cover deepening losses and rushed out of crowded positions in stocks. The erratic trade evoked memories of last March and comes as the pandemic recovery enters a delicate phase, with financial markets moving swiftly to price in an end to the cheap money that had lit a fire under world stocks for a year. Australia's central bank launched a surprise bond buying operation to try and staunch the bleeding, calming cash markets but barely taming the fear, evident in more liquid futures trade.
Jordan Storey, 28, was tortured and subjected to a a violent attack by a gang of four people at a flat in Whitley Bay, Newcastle, in February last year.
A Wall Street selloff sparked by surging bond yields spread to Asia and Europe. Stock futures were trying to stabilize.
Feb. 26—So many weapons, so many ways. Michigan can beat teams inside and outside, upside and downside. And then, when presented with an especially sizable challenge, they can do something else. They can chop it down to size with a fierce, disciplined defense. As good as the Wolverines have been the past decade or so, we haven't seen anything quite like this, with furiously motivated seniors ...
The "Small Molecule Drug Discovery Market Research and Outlook, 2020 - Trends, Growth Opportunities and Forecasts to 2028" report has been added to ResearchAndMarkets.com's offering.
Feb. 26—Not even a week ago, not many expected much out of Michigan State over the final two weeks of the regular season. The Spartans were mired near the bottom of the Big Ten standings and weren't even in the bubble discussion when it came to the NCAA Tournament. Add in the fact they were getting set to play six games in the final 13 games of the season with four of those games coming ...
Feb. 26—ANN ARBOR — Michigan's defense has passed its share of tests throughout the Big Ten season. On Thursday night, the Wolverines faced their biggest one yet in a top-10 matchup against national player of the year candidate Luka Garza and Iowa's high-scoring attack. Once again, No. 3 Michigan rose to the occasion and made another statement in its quest for the regular-season conference ...